A pivotal registration phase III, multicenter, randomized tuberculosis controlled trial: design issues and lessons learnt from the Gatifloxacin for TB (OFLOTUB) project

BACKGROUND: There have been no major advances in tuberculosis (TB) drug development since the first East African/British Medical Research Council short course chemotherapy trial 35 years ago. Since then, the landscape for conducting TB clinical trials has profoundly changed with the emergence of HIV...

Descripción completa

Detalles Bibliográficos
Autores principales: Merle, Corinne SC, Sismanidis, Charalambos, Sow, Oumou Bah, Gninafon, Martin, Horton, John, Lapujade, Olivier, Lo, Mame Bocar, Mitchinson, Denis A, Perronne, Christian, Portaels, Francoise, Odhiambo, Joseph, Olliaro, Piero, Rustomjee, Roxana, Lienhardt, Christian, Fielding, Katherine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Methodology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3528451/
https://www.ncbi.nlm.nih.gov/pubmed/22607233
http://dx.doi.org/10.1186/1745-6215-13-61

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3528451/
https://www.ncbi.nlm.nih.gov/pubmed/22607233
http://dx.doi.org/10.1186/1745-6215-13-61

Ejemplares similares